A delegation from Yale Cancer Center (YCC) went to Capitol Hill on May 16 to stress the life-saving urgency of continuing to fund National Institutes of Health cancer and other biomedical research during these difficult budget times.Dr. Roy Herbst, chief...
There has long been concern that people with implantable cardioverter-defibrillators (ICDs) should not participate in any kind of strenuous sports activity for fear that their devices could fail. But a new Yale study finds that many athletes with ICDs can...
Dr. Lieping Chen, newly appointed as the United Technologies Corporation Professor in Cancer Research, focuses his research on developing new treatment options for cancer. His laboratory discovered the B7-H1/PD-1 immune inhibitory pathway and established...
Dr. Roy S. Herbst, recently designated as the Ensign Professor of Medical Oncology, is nationally recognized for his leadership and expertise in lung cancer treatment and research. His primary mission is the enhanced integration of clinical, laboratory,...